Section Arrow
BGM.NASDAQ
- BGM Group Ltd
Quotes are at least 15-min delayed:2024/11/10 17:20 EST
Last
 7.3101
-0.2899 (-3.81%)
Day High 
7.55 
Prev. Close
7.6 
1-M High
Volume 
11.45K 
Bid
7.13
Ask
7.7
Day Low
6.91 
Open
7.15 
1-M Low
6.4 
Market Cap 
54.92M 
Currency USD 
P/E -- 
%Yield 0.92 
10-SMA 7.55 
20-SMA 7.58 
50-SMA 7.4 
52-W High 8.96 
52-W Low 1.7755 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.10/--
Enterprise Value
54.95M
Balance Sheet
Book Value Per Share
6.01
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
46.47M
Operating Revenue Per Share
8.66
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands1.49-0.06-3.87%-- 
ESPREsperion Therapeutics2.275+0.165+7.82%-- 
VTRSViatris12.96-0.22-1.67%227.2PE
HLNHaleon plc9.61+0.01+0.10%31.1PE
CGCCanopy Growth Corp4.24-0.31-6.81%-- 
Quotes are at least 15-min delayed:2024/11/10 17:20 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Qilian International Holding Group Ltd is a pharmaceutical and chemical company. The company is engaged in the development, manufacture, marketing, and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives products, heparin products, sausage casings, and fertilizers. It operates through three segments namely, Oxytetracycline and Licorice products and TCMD; Fertilizer; and Heparin products and Sausage casing. Oxytetracycline and Licorice products and TCMD segment generates majority of the revenue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.